BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5038775)

  • 1. [Therapy of hyperammonemia: effect of a preparation arginine pyrrolidonecarboxylate, taurine, vitamin B6 and citric acid].
    Verzetti G; Emanuelli G; Montagnani M
    Clin Ter; 1972 Mar; 60(5):429-38. PubMed ID: 5038775
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood ammonia antagonistic and hepatoprotective effect of a combination of arginine, taurine and vitamin B6 pyrrolidon-carboxylate].
    Di Rosa M
    Clin Ter; 1967 Sep; 42(6):499-507. PubMed ID: 5618919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of serum ammonium in various pediatric diseases in relation to the treatment with anti-ammonemic drugs].
    Riva E; Borzani M; Motta G; Giovannini M
    Minerva Pediatr; 1976 Jul; 28(24):1515-23. PubMed ID: 1012194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatic encephalopathy and selective amino acid solutions].
    De Martiis M; D'Ottavi R; Fontana M; Patrizi P
    Clin Ter; 1983 Jan; 104(1):53-8. PubMed ID: 6337772
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of alcoholic hepatic steatosis with metadoxine. Preliminary results on the evaluation of the effects of the drug by an ultrasonographic study].
    Sergiacomo L; Ciancaglini R; Orlando D; Delle Monache G; Pesa O
    Clin Ter; 1986 Oct; 119(2):133-41. PubMed ID: 3539468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatic damage caused by drugs and evaluation of the therapeutic effectiveness of pyridoxine pyrrolidone carboxylate].
    Nami R
    Clin Ter; 1979 Oct; 91(1):41-55. PubMed ID: 546575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metadoxine in alcohol-related pathology].
    Santoni S; Corradini P; Zocchi M; Camarri F
    Clin Ter; 1989 Jul; 130(2):115-22. PubMed ID: 2529084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I; Szentner J; Hegedüs-Wein I; Vass A
    Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic use of metadoxine in alcohol-related mental and behavioral disorders].
    Carboni MA; Corsa R
    Clin Ter; 1987 Dec; 123(6):469-73. PubMed ID: 2972505
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metadoxine in the treatment of vomiting in uremic patients under dialysis treatment].
    Di Paolo N; De Mia M; Gaggiotti E
    Clin Ter; 1984 Aug; 110(3):221-9. PubMed ID: 6237861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metadoxine in the control of oxidative stress caused by acute and chronic ethanol poisoning].
    Calabrese V; de Bernardis E; Rizza V
    Boll Soc Ital Biol Sper; 1986 Nov; 62(11):1357-63. PubMed ID: 3828134
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic encephalopathy: comparative study of EEG abnormalities, neuropsychic disturbances and blood ammonia.
    Demedts M; Pillen E; De Groote J; Van de Woestijne KP
    Acta Neurol Belg; 1973; 73(5):281-8. PubMed ID: 4785018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic activity of a combined taurine-nucleotide-vitamin product in some states of hepatic disease].
    Piazza V
    Omnia Med Ther; 1966; 4(2):521-8. PubMed ID: 5962154
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hepatic coma: use of certain Krebs' urea cycle intermediates (L-arginine, DL-ornithine).
    WOLFE SJ; FAST BB; STORMONT JM; DAVIDSON CS
    J Lab Clin Med; 1958 May; 51(5):672-89. PubMed ID: 13539483
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nutramin C Spofa in treatment of hepatic encephalopathy and hepatic coma].
    Vavros B; Kruf M
    Vnitr Lek; 1977 Jun; 23(6):597-608. PubMed ID: 883136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amnoniacal detoxication and cerearal metabolism].
    Nordmann R
    Cah Coll Med Hop Paris; 1967 Mar; 8(3):185-90. PubMed ID: 5614605
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic effectiveness of pyridoxine pyrrolidonecarboxylate in febrile convulsions in children].
    Riva E; Borzani M; Motta G; Giovannini M
    Minerva Pediatr; 1977 Oct; 29(33):2001-8. PubMed ID: 593236
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical considerations on the therapeutic action of Nucleodoxine].
    Idéo G
    Omnia Med Ther; 1968; 46(2):409-15. PubMed ID: 5739611
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arginine pyrollidone carboxylate associated with glutamine and pyridoxine in the treatment of enuresis].
    Mastronuzzi G
    Omnia Med Ther; 1968; 46(4):893-907. PubMed ID: 5743250
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic contribution of pyrodoxine pyrrolidinecarboxylate. (Notes on antiseborrheic treatment).
    Ghittoni S; Orsucci O; Saviozzi A; Simonini P
    Ital Gen Rev Dermatol; 1978; 15(1):39-61. PubMed ID: 162287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.